Suppr超能文献

二尖瓣夹闭术后失败的二尖瓣手术:单中心经验。

Mitral Valve Surgery After Failed MitraClip: A Single-Center Experience.

机构信息

Smidt Heart Institute, Cedars-Sinai Medical Center, 127 San Vincente Blvd, AHSP A3408, Los Angeles, CA 90048 USA.

出版信息

J Invasive Cardiol. 2021 Apr;33(4):E236-E243. doi: 10.25270/jic/20.00486.

Abstract

OBJECTIVE

To evaluate candidacy for surgical mitral valve (MV) repair of recurrent mitral regurgitation (MR) after failed MitraClip.

BACKGROUND

Percutaneous mitral repair with MitraClip is safe and effective in patients with degenerative and functional MR with high surgical risk. However, some patients require subsequent mitral surgery for recurrence of significant MR.

METHODS

This single-center, observational study includes consecutive patients who underwent mitral surgery after failed MitraClip.

RESULTS

Twenty-five patients (age, 69 ± 15 years; 52% women) with severe symptomatic MR after failed MitraClip implantation underwent mitral surgery after a median interval of 5.1 months (interquartile range, 2.5-14 months). Ten patients underwent MV repair (8 with robotic minithoracotomy) and 15 underwent MV replacement (most with sternotomy). Two patients in whom MV repair was intended underwent MV replacement because MitraClip-related leaflet damage prohibited repair. Examples of relative contraindication for MV repair that led to pursuing MV replacement were advanced patient age in 4 patients (mean age, 85 ± 7.6 years), endocarditis in 1 patient, and severely calcified or rheumatic leaflets in 5 patients. Perioperative complications were rare and intermediate-term mortality was similar between groups (3 patients in the MV repair group [30%] vs 4 patients in the MV replacement group [27%]; P=.90).

CONCLUSION

When performed by an experienced mitral surgeon and within 1 year of failed MitraClip implantation, surgical MV repair is feasible in most patients who were surgical repair candidates before the clip. Having the option for surgical MV repair after failed MitraClip is important to preserve optimal long-term outcomes for patients who undergo transcatheter mitral repair with MitraClip, especially as ongoing trials are shifting to study lower-risk patients who are also candidates for surgical repair.

摘要

目的

评估二尖瓣修复术修复二尖瓣修复术(MitralClip)治疗失败后复发性二尖瓣反流(MR)的手术适应证。

背景

经皮二尖瓣修复术伴 MitraClip 治疗退行性和功能性 MR 伴高手术风险的患者安全有效。然而,一些患者因严重 MR 复发而需要随后进行二尖瓣手术。

方法

这项单中心、观察性研究纳入了因 MitraClip 治疗失败而接受二尖瓣手术的连续患者。

结果

25 例(年龄 69±15 岁;52%为女性)因 MitraClip 植入后严重症状性 MR 而行二尖瓣手术,中位间隔时间为 5.1 个月(四分位距 2.5-14 个月)。10 例患者行二尖瓣修复术(8 例行机器人小开胸术),15 例行二尖瓣置换术(多数患者行胸骨切开术)。2 例原本计划行二尖瓣修复术的患者因 MitraClip 相关瓣叶损伤而不得不转为二尖瓣置换术。导致选择二尖瓣置换术而不是修复术的相对禁忌证包括 4 例患者年龄较大(平均年龄 85±7.6 岁)、1 例感染性心内膜炎和 5 例严重钙化或风湿性瓣叶。围手术期并发症罕见,两组间中期死亡率相似(二尖瓣修复组 3 例[30%],二尖瓣置换组 4 例[27%];P=0.90)。

结论

由经验丰富的二尖瓣外科医生在 MitraClip 治疗失败后 1 年内进行手术,对于大多数在接受 MitraClip 经导管二尖瓣修复术之前是手术修复候选者的患者,行二尖瓣修复术是可行的。在 MitraClip 治疗失败后提供二尖瓣修复术的选择对于行经导管二尖瓣修复术的患者保持最佳长期结局很重要,特别是随着正在进行的试验转向研究也适合手术修复的低危患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验